Valuation: Medico Intercontinental Limited

Market Cap 255M 2.65M 2.32M 2.14M 1.98M 3.73M 3.8M 25.58M 10.03M 125M 9.97M 9.75M 430M P/E 2024
10.1x
P/E 2025 7.01x
Enterprise Value 397M 4.14M 3.62M 3.34M 3.09M 5.81M 5.92M 39.85M 15.64M 195M 15.54M 15.19M 670M EV / Sales 2024
0.58x
EV / Sales 2025 0.52x
Free-Float
38.75%
Yield 2024 *
-
Yield 2025 -
05-22 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-14 Medico Intercontinental Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
25-08-14 Medico Intercontinental Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-07-14 Medico Intercontinental Limited Approves the Appointment of Puneeta Sharma as Company Secretary and Compliance Officer, Effective from 14 July, 2025 CI
25-05-30 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025 CI
25-04-22 Medico Intercontinental Limited Announces Resignation of Puneeta Sharma as Company Secretary & Compliance Officer, Effective 22 April, 2025 CI
24-11-14 Medico Intercontinental Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-08-13 Medico Intercontinental Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
24-05-25 Medico Intercontinental Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
24-05-25 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
24-04-25 Medico Intercontinental Limited Announces Resignation of Nikul Dipakbhai Shah as Independent Director CI
24-04-09 Medico Intercontinental Limited Proposes to Incorporate Joint Venture Partnership Firm CI
24-02-14 Medico Intercontinental Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
1 day-4.00%
1 week-8.39%
Current month-11.01%
1 month+6.19%
3 months-11.55%
6 months-30.45%
Current year-33.92%
1 week 25.31
Extreme 25.31
29.5
1 month 23.05
Extreme 23.05
35.7
Current year 20.61
Extreme 20.61
42.9
1 year 20.61
Extreme 20.61
43
3 years 20.61
Extreme 20.61
122
5 years 20.61
Extreme 20.61
122
10 years 8
Extreme 8
132.1
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2019-08-11
Compliance Officer - 2019-05-31
Director TitleAgeSince
Chairman - 2019-04-07
Director/Board Member 53 2019-03-22
Director/Board Member - 2022-11-13
Change 5-day change 1-year change 3-year change Capi.($)
-4.00%-8.39%-31.40%-63.73% 2.88M
+1.10%+2.06%+15.45%+81.05% 48.17B
-0.64%-2.02%+66.01%+110.77% 35.47B
+0.80%-0.94%-3.09%+39.50% 12.04B
+0.20%-1.68%+17.05%+90.41% 11.79B
+1.53%+0.38%+32.83%+126.50% 9.15B
+1.09%-2.04%+18.52%+37.49% 6.91B
-1.89%-4.08%+43.70%-5.26% 6.95B
+0.17%+1.77%+3.87%+228.32% 6.79B
+3.56%-6.15%-20.01%+13.39% 5.77B
Average +0.20%-1.95%+14.29%+65.84% 14.3B
Weighted average by Cap. +0.52%-1.88%+27.21%+86.56%

Financials

2024 2025
Net sales 715M 7.44M 6.51M 6.01M 5.56M 10.46M 10.65M 71.72M 28.14M 350M 27.96M 27.35M 1.21B 963M 10.02M 8.76M 8.1M 7.48M 14.09M 14.34M 96.56M 37.89M 471M 37.65M 36.82M 1.62B
Net income 39.47M 411K 359K 332K 307K 578K 588K 3.96M 1.55M 19.33M 1.54M 1.51M 66.55M 50.57M 527K 460K 425K 393K 740K 753K 5.07M 1.99M 24.76M 1.98M 1.93M 85.27M
Net Debt 14.89M 155K 135K 125K 116K 218K 222K 1.49M 586K 7.29M 582K 569K 25.11M 142M 1.48M 1.3M 1.2M 1.11M 2.08M 2.12M 14.28M 5.6M 69.7M 5.57M 5.44M 240M
Logo Medico Intercontinental Limited
Medico Intercontinental Ltd is engaged in the business of trading pharmaceutical products. It provides a platform for all research-based biopharmaceutical companies. Its product categories include Gastro, Uro, Nutrition, Cosmetology, Health devices, Hospital, and other areas. Its products include ACIFACT-BLI, ACIFACT-P, ACIFACT-SP (ALU-ALU), ALBECTIN, ALFACARE-D3, ARSUFACT Combokit, BALOFACT, CYCLOFACT 400, UDIFACT 150, XOFACT-4, ZIFT SL-250, ZYMIX, ARGIFACT, CLIANCIACT POWDER, RELIEVE CZ, VOLIREX SPRAY, RACIMAX SACHET, PERMACT, OROFACT, KTZ, FEMYACT, LIVOFACT, ZYMIX SY, ULTRATONE SY, ALBECTIN SUS, BECOFACT DROPS, MEFACT P SUS, ONCARE SOLUTION, OFCARE-FORTE SUS, PRODOM CV SY, RELIBEN SUSP, ZIFT SUSP-200, MGCIPACT EYE DROP, OROFACT-PASTE (lamy), OROFACT MOUTH ULCER GEL, CAMBOGIA, LUBRIACT, HIZEN, and CALAMED LOTION. Its subsidiaries include Evagrace Pharma Private Limited, Ritz Formulations Private Limited, Sungrace Pharma Private Limited, and Azillian Healthcare Private Limited.
Employees
38
Date Price Change Volume
26-07-14 ₹26.43 -4.00% 736
26-07-13 ₹27.53 -1.92% 1,381
26-07-10 ₹28.07 +1.34% 114
26-07-09 ₹27.70 -0.18% 950
26-07-08 ₹27.75 -3.81% 1,601
  1. Stock Market
  2. Stocks
  3. 539938 Stock